Cover Image
市場調查報告書

Huabo Biopharm Co., Ltd.的產品平台分析

Huabo Biopharm Co., Ltd. - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 319977
出版日期 內容資訊 英文 24 Pages
訂單完成後即時交付
價格
Back to Top
Huabo Biopharm Co., Ltd.的產品平台分析 Huabo Biopharm Co., Ltd. - Product Pipeline Review - 2015
出版日期: 2015年12月23日 內容資訊: 英文 24 Pages
簡介

Huabo Biopharm Co., Ltd.總公司在中國,有Zhejiang Huahai Pharmaceuticals Co., Ltd.子公司的生物科技企業。雙功能蛋白質,及結構域蛋白質、利用抗體工程等的平台研究開發、商品腫瘤治療的新藥。

本報告提供Huabo Biopharm Co., Ltd.的治療藥開發平台的現狀及各開發階段比較分析、各藥物標靶、作用機制、給藥途徑、分子類型的治療藥的評估、最新的企業新聞和發表、後期階段及中止的計劃相關資訊等。

目錄

Huabo Biopharm Co., Ltd.的基本資料

  • Huabo Biopharm Co., Ltd.概要
  • 主要資訊
  • 企業資料

Huabo Biopharm Co., Ltd.:R&D概要

  • 主要的治療範圍

Huabo Biopharm Co., Ltd.:開發平台的檢討

  • 各開發階段的開發中產品
  • 單劑產品

Huabo Biopharm Co., Ltd.:開發中產品概況

  • 初期階段的開發中產品
    • 前臨床階段的產品/聯合治療模式
    • 藥物研發階段的產品/聯合治療模式

Huabo Biopharm Co., Ltd.:藥物簡介

  • HB-001
  • HB-002.1
  • HB-005db
  • HB-002
  • HB-004
  • HB-006
  • HB-008

Huabo Biopharm Co., Ltd.:開發平台分析

  • 各標靶
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

Huabo Biopharm Co., Ltd.:總公司和子公司的所在地

  • 總公司

附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07899CDB

Summary

Global Markets Direct's, 'Huabo Biopharm Co., Ltd. - Product Pipeline Review - 2015', provides an overview of the Huabo Biopharm Co., Ltd.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Huabo Biopharm Co., Ltd.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Huabo Biopharm Co., Ltd. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Huabo Biopharm Co., Ltd.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Huabo Biopharm Co., Ltd.'s pipeline products

Reasons to buy

  • Evaluate Huabo Biopharm Co., Ltd.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Huabo Biopharm Co., Ltd. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Huabo Biopharm Co., Ltd.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Huabo Biopharm Co., Ltd. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Huabo Biopharm Co., Ltd.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Huabo Biopharm Co., Ltd. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Huabo Biopharm Co., Ltd. Snapshot
    • Huabo Biopharm Co., Ltd. Overview
    • Key Information
    • Key Facts
  • Huabo Biopharm Co., Ltd. - Research and Development Overview
    • Key Therapeutic Areas
  • Huabo Biopharm Co., Ltd. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Huabo Biopharm Co., Ltd. - Pipeline Products Glance
    • Huabo Biopharm Co., Ltd. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
  • Huabo Biopharm Co., Ltd. - Drug Profiles
    • HB-001
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • HB-002.1
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • HB-005db
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • HB-008
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • HB-002
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • HB-004
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • HB-006
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Huabo Biopharm Co., Ltd. - Pipeline Analysis
  • Huabo Biopharm Co., Ltd. - Pipeline Products by Target
  • Huabo Biopharm Co., Ltd. - Pipeline Products by Molecule Type
  • Huabo Biopharm Co., Ltd. - Pipeline Products by Mechanism of Action
  • Huabo Biopharm Co., Ltd. - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Huabo Biopharm Co., Ltd., Key Information
  • Huabo Biopharm Co., Ltd., Key Facts
  • Huabo Biopharm Co., Ltd. - Pipeline by Indication, 2015
  • Huabo Biopharm Co., Ltd. - Pipeline by Stage of Development, 2015
  • Huabo Biopharm Co., Ltd. - Monotherapy Products in Pipeline, 2015
  • Huabo Biopharm Co., Ltd. - Preclinical, 2015
  • Huabo Biopharm Co., Ltd. - Discovery, 2015
  • Huabo Biopharm Co., Ltd. - Pipeline by Target, 2015
  • Huabo Biopharm Co., Ltd. - Pipeline by Molecule Type, 2015
  • Huabo Biopharm Co., Ltd. - Pipeline Products by Mechanism of Action, 2015

List of Figures

  • Huabo Biopharm Co., Ltd. - Pipeline by Top 10 Indication, 2015
  • Huabo Biopharm Co., Ltd. - Pipeline by Stage of Development, 2015
  • Huabo Biopharm Co., Ltd. - Monotherapy Products in Pipeline, 2015
  • Huabo Biopharm Co., Ltd. - Pipeline by Top 10 Target, 2015
  • Huabo Biopharm Co., Ltd. - Pipeline by Top 10 Molecule Type, 2015
  • Huabo Biopharm Co., Ltd. - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top